Physician profile
William W Lee
NPI 1083788145
$2,859.16
in general payments reported to CMS, 2019-2025
28 companies · $483 in 2025
The $483 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $192 · 2021: $682 · 2022: $658 · 2023: $317 · 2024: $146 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $846.02 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $530.41 | 2019-2025 | |
| Novo Nordisk INC | $226.23 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $205.64 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $201.46 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $200.72 | 2021-2025 | Verquvo, Steglatro, Belsomra |
| Cvrx, INC. | $192.52 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $191.95 | 2021-2024 | |
| Pfizer INC. | $178.18 | 2020-2025 | |
| Philips North America LLC | $160.09 | 2023-2025 | Technical Education Mri |
| Boston Scientific Corporation | $136.11 | 2020-2023 | Watchman |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.69 | 2019-2023 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.68 | 2019 | |
| Amarin Pharma, INC. | $69.03 | 2020-2022 | |
| Itamar Medical INC | $60.15 | 2022 | |
| Abiomed | $42.98 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $40.30 | 2020-2022 | |
| Btg International INC. | $39.13 | 2019 | |
| Bard Peripheral Vascular, INC. | $28.59 | 2022 | |
| Cardiva Medical, INC. | $24.00 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Amryt Pharma Holdings LTD | $19.16 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.30 | 2025 | |
| Terumo Medical Corporation | $16.36 | 2020 | |
| Sanofi-Aventis U.S. LLC | $14.71 | 2022 | |
| Sanofi Pasteur INC. | $14.53 | 2019 | |
| Abbvie INC. | $13.95 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.60 | 2021 | |
| Abbott Laboratories | $12.44 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.